Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.

Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. Abstract Text:

    susama vermaSusama Verma,katia cikurelKatia Cikurel,igor j koralnikIgor J Koralnik,susan morgelloSusan Morgello,charlotte cunningham-rundlesCharlotte Cunningham-Rundles,zelig r weinsteinZelig R Weinstein,christine bergmannChristine Bergmann,david m simpsonDavid M Simpson,susama vermaSusama Verma,katia cikurelKatia Cikurel,igor j koralnikIgor J Koralnik,susan morgelloSusan Morgello,charlotte cunningham-rundlesCharlotte Cunningham-Rundles,zelig r weinsteinZelig R Weinstein,christine bergmannChristine Bergmann,david m simpsonDavid M Simpson,

    Progressive multifocal leukoencephalopathy (PML) is a usually fatal cerebral white matter disease found in patients with human immunodeficiency virus infection and other immunocompromised states. We present the case of a 63-year-old woman with polycythemia vera who developed a progressive focal neurological deficit with white matter abnormalities on magnetic resonance images of the brain that was proved on biopsy to be PML. She was treated with the serotonin reuptake inhibitor mirtazapine and remains neurologically stable, with resolution of cerebral lesions, >2 years after diagnosis. We propose that mirtazapine should be investigated further for use in PML.

    Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. Publishing Authors By Initials

    s vermaS Verma,k cikurelK Cikurel,ij koralnikIJ Koralnik,s morgelloS Morgello,c cunningham-rundlesC Cunningham-Rundles,zr weinsteinZR Weinstein,c bergmannC Bergmann,dm simpsonDM Simpson,s vermaS Verma,k cikurelK Cikurel,ij koralnikIJ Koralnik,s morgelloS Morgello,c cunningham-rundlesC Cunningham-Rundles,zr weinsteinZR Weinstein,c bergmannC Bergmann,dm simpsonDM Simpson,

    For similar chemical actions and uses: pharmacologic actions: molecular mechanisms of pharmacological action: neurotransmitter agents: neurotransmitter uptake inhibitors: serotonin uptake inhibitors research abstracts see: chemical actions and uses: pharmacologic actions: molecular mechanisms of pharmacological action: neurotransmitter agents: neurotransmitter uptake inhibitors: serotonin uptake inhibitors research

    PUBMED ID PMID:

    MEDLINE DATE:

    Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Journal of infectious diseases

    VOLUME: 196

    Page Numbers: 709-11

    Journal Abbreviation: J. Infect. Dis.

    ISSN: 0022-1899

    DAY: 13

    MONTH: 07

    YEAR: 2007

    Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 413675

    Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. Keywords Mesh Terms:

    KEYWORDS: Serotonin Uptake Inhibitors

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. Information

    Substance Name: mirtazapine

    Registry Number: 61337-67-5

    Grant and Affiliation Information for Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera.

    AFFILIATION: Department of Neurology, Mount Sinai Medical Center, New York, NY 10029, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIMH

    GRANT: R24MH59724

    ACRONYM: MH

    MEDLINETA: J Infect Dis

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News